These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 12433000

  • 1. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y.
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K, Fukushima S, Mizuhashi S, Jinnin M, Makino T, Inoue Y, Ihn H.
    Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
    [Abstract] [Full Text] [Related]

  • 8. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
    Tosti A, Guidetti MS, Bardazzi F, Misciali C.
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
    [Abstract] [Full Text] [Related]

  • 9. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E, Şentürk N.
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [Abstract] [Full Text] [Related]

  • 10. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G, Malagoli P, Santagostino L.
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [Abstract] [Full Text] [Related]

  • 11. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y, Hatamochi A, Hamasaki Y, Suzuki H, Ikeda H, Yamazaki S.
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [Abstract] [Full Text] [Related]

  • 12. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S, Kishi Y, Hino H.
    J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Starace M, Vezzoni R, Alessandrini A, Bruni F, Carpanese MA, Misciali C, Sechi A, Piraccini BM.
    Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.